Brigit Biofarmaka Teknologi Tbk. vs Bima Sakti Pertiwi Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Bima Sakti Pertiwi Tbk. trades at Rp56 (market cap 175B, 6.71M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. and Bima Sakti Pertiwi Tbk. are close in size by market cap, and Bima Sakti Pertiwi Tbk. is more actively traded (6.71M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | PAMG | |
|---|---|---|
Market Cap | 164.65B | 175B |
Volume | 62.5K | 6.71M |
Lot | 625 | 67.12K |
Turnover | 15.03M | 376.74M |
Average Price | 240.55 | 56.13 |
Value | 15.03M | 376.74M |
Indicative Equilibrium Price | 238 | 56 |
Indicative Equilibrium Volume | 100 | 1.36K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Bima Sakti Pertiwi Tbk (the Company) was established based on the Notarial Deed of Raden Minarno Hardjokoesoemo, S.H., Deputy Notary in Tanjungpinang, No. 30, dated April 28, 1980.
Read more on PAMG →